Abound Wealth Management Ark Genomic Revolution ETF (De Transaction History
Abound Wealth Management
- $427 Billion
- Q4 2025
A detailed history of Abound Wealth Management transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Abound Wealth Management holds 104 shares of ARKG stock, worth $2,796. This represents 0.0% of its overall portfolio holdings.
Number of Shares
104Holding current value
$2,796% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding ARKG
# of Institutions
298Shares Held
20.4MCall Options Held
2.53MPut Options Held
2.8M-
Jpmorgan Chase & CO New York, NY3.94MShares$106 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.83MShares$76.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY2.16MShares$58.1 Million0.01% of portfolio
-
Citigroup Inc1.52MShares$40.8 Million0.02% of portfolio
-
Ubs Group Ag1.12MShares$30.1 Million0.01% of portfolio